Skip to content

Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma

Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06844461
Acronym
QOL-DR-NEUROMA
Enrollment
40
Registered
2025-02-25
Start date
2024-01-20
Completion date
2025-04-30
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acoustic Schwannoma, Quality of Life Outcomes

Brief summary

Italian translation and validation study of two different questionnaire (VSQOL and DRS) about quality of life in patient with acoustic schwannoma.

Interventions

None listed

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with sporadic acoustic neuroma in follow-up with wait and scan protocol or treated with microsurgical resection with any approach

Exclusion criteria

* Patient with NF2 * Patient previuosly treated with RT in the head and neck district * Patient with pre-treatment facial palsy ipsi and controlateral * Patient non native italian speakers * Patient with major mental illness already existing before the acoustic neuroma diagnosis * Patient with neurological issues such as chronic migraine or postural instability already existing before the acoustic neuroma diagnosis

Design outcomes

Primary

MeasureTime frameDescription
VSQOL-ItFrom the surgery to the enrollment time (6 months post-treatment) for surgical group. At baseline at enrollment for wait-and-scan groupSelf evaluation of quality of life in patient diagnosed with sporadic acoustic neuroma. It is composed of 40 questions, of which 37 are built on a Likert scale from 1 to 5, where 1 indicates strong disagreement and 5 indicates strong agreement, and 3 with 3 possible answers. The questions relate to 8 domains: Hearing Problems, Postural Instability and Imbalance, Pain, Discomfort, and Tinnitus, Facial or Ocular Issues, Impact on Physical, Emotional, and Social Well-being, Difficulties with Thinking and Memory, Satisfaction or Regret, Impact on Work Activity. The score of questions 1 to 33 is reversed, so that a higher score indicates a favorable health status or better quality of life. The scores for questions 1 to 33 are linearly transformed onto a scale from 0 to 100, where 0 indicates poor quality of life and 100 indicates ideal quality of life. The overall score of the index is calculated as the average of the scores of the first six domains, excluding SatisfactionRegret domain
DRS-ItFrom the surgery to the enrollment time (6 months post-treatment) for surgical group. At baseline at enrollment for wait-and-scan groupDecisional regret scale to evaluate any regret about the therapeutic choice both in wait-and-scan cohort and surgical cohort. The score ranges from 0 (no regret) to 100 (complete regret). Patients with more than 25pts are considered to have moderate/high regret

Secondary

MeasureTime frameDescription
PANQOLFrom the surgery to the enrollment time (6 months post-treatment) for surgical group. At baseline at enrollment for wait-and-scan groupSpecific quality of life questionnaire in patient with acoustic neuroma composed of 26 questions built on a Likert scale from 1 to 5, where 1 indicates strong disagreement and 5 indicates strong agreement. The questions relate to 7 domains: Hearing (4 questions), Balance (6 questions), Facial Function (3 questions), Energy (6 questions), Anxiety (4 questions), General Health Status (2 questions), and Pain (1 question). The score for each domain is calculated as the average of the responses to the questions assigned to it and is linearly transformed onto a scale from 0 to 100, where 0 indicates poor quality of life and 100 indicates ideal quality of life. The overall score of the scale is calculated as the average of the scores of the individual domains.
DASS-21 QuestionnaireFrom the surgery to the enrollment time (6 months post-treatment) for surgical group. At baseline at enrollment for wait-and-scan groupPsychometric self-evaluation of depression, anxiety and stress during the study period. 21 items-questionnaire about depression, anxiety and stress during the study period. Each subscale presents a singular score from 0 to 42. Higher scores corresponds to worse emotional outcome.

Countries

Italy

Contacts

Primary ContactCecilia Botti, ENT Specialist
cecilia.botti@aosp.bo.it+39 0512143266
Backup ContactAlessandro Rosti, PhD Student
alessandro.rosti3@studio.unibo.it+39 3462245614

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026